How will Trump's tax bill impact startup stock gains?
Why did Tesla’s top sales executive depart?
What caused the halt of US-Canada trade talks?
How did S&P 500 reach an all-time high today?
Why is Apple promoting its 'F1' movie aggressively?
How will Biden's trade deal affect global markets?
What risks do analysts see in rising AI stocks?
BioCryst Just Ditched Its Europe Business — Here's Why Investors Are Cheering
benzinga.com/m-a/25/06/46142142/biocryst-just-ditched-its-europe-business-heres-why-investors-are-cheering
BioCryst Pharmaceuticals (NASDAQ:BCRX) agrees to sell its European Orladeyo (berotralstat) business to Neopharmed Gentili for up to $264 million.
Orladeyo (berotralstat) is the first and only oral therapy designed specifically to prevent attacks of hereditary angioedema (HAE) in adult and…
This story appeared on benzinga.com, 2025-06-27 14:41:23.